Pliant Therapeutics

PLRX • NASDAQ • Stock Fundamentals

Pliant Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bernard Coulie, with a market cap of $70.6M.

Market Cap$70.6M

Employees158.0

CEOBernard Coulie

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Pliant Therapeutics

Pliant Therapeutics (PLRX) has a market capitalization of $70.6M and trades on NASDAQ.

Pliant Therapeutics has approximately 158 employees.